Shanghai Henlius Biotech, Inc. 上海復宏漢霖生物技術股份有限公司
Sanction of Shanghai Henlius Biotech (2696) and ex-CEO Scott Liu Shi Kau
SEHK, 2-Sep-2025
For diverting all of the proceeds of the IPO Placing arranged by AMTD Global Markets (now oOo Securities) into an "investment management agreement" under AMTD.
SEHK, 2-Sep-2025
For diverting all of the proceeds of the IPO Placing arranged by AMTD Global Markets (now oOo Securities) into an "investment management agreement" under AMTD.
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy